The lncRNA XIST/miR‐125b‐2‐3p axis modulates cell proliferation and chemotherapeutic sensitivity via targeting Wee1 in colorectal cancer

Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancers

(2020) Yun Wang et al.   CANCER LETTERS

Inhibiting Wee1 and ATR kinases produces tumor-selective synthetic lethality and suppresses metastasis

(2019) Amirali B. Bukhari et al.   JOURNAL OF CLINICAL INVESTIGATION

Discovery and Validation of Circulating Biomarkers of Colorectal Adenoma by High-Depth Small RNA Sequencing

(2018) Brian S. Roberts et al.   CLINICAL CANCER RESEARCH

MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer

(2018) Ying Zhang et al.   Molecular Cancer

Identifying miRNA and gene modules of colon cancer associated with pathological stage by weighted gene co-expression network analysis

(2018) Xian-guo Zhou et al.   OncoTargets and Therapy

MicroRNA-181a promotes angiogenesis in colorectal cancer by targeting SRCIN1 to promote the SRC/VEGF signaling pathway

(2018) Wu Sun et al.   Cell Death & Disease

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Long noncoding RNA XIST expedites metastasis and modulates epithelial–mesenchymal transition in colorectal cancer

(2017) Dong-liang Chen et al.   Cell Death & Disease

Therapeutic Inhibition of miR-4260 Suppresses Colorectal Cancer via Targeting MCC and SMAD4

(2017) Junjie Xiao et al.   Theranostics

Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer

(2016) H. Imaoka et al.   ANNALS OF ONCOLOGY

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression

(2016) Dong-liang Chen et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Systematic Discovery of Xist RNA Binding Proteins

(2015) Ci Chu et al.   CELL

Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer

(2015) Keun Hur et al.   GUT

WEE1 Kinase As a Target for Cancer Therapy

(2015) Sabine Mueller et al.   JOURNAL OF CLINICAL ONCOLOGY

The Epidermal Growth Factor Receptor Responsive miR-125a Represses Mesenchymal Morphology in Ovarian Cancer Cells

(2015) Karen D. Cowden Dahl et al.   NEOPLASIA

Genetic inhibition of the atypical kinase Wee1 selectively drives apoptosis of p53 inactive tumor cells

(2014) William N Pappano et al.   BMC CANCER

Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions

(2014) Ana Slipicevic et al.   GYNECOLOGIC ONCOLOGY

Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma

(2014) Peter S Harris et al.   Molecular Cancer

Efficient Induction of Apoptosis by Wee1 Kinase Inhibition in Hepatocellular Carcinoma Cells

(2014) Tomomi Kogiso et al.   PLoS One

Serum miR-200c Is a Novel Prognostic and Metastasis-Predictive Biomarker in Patients With Colorectal Cancer

(2013) Yuji Toiyama et al.   ANNALS OF SURGERY

Serum miR-21 as a Diagnostic and Prognostic Biomarker in Colorectal Cancer

(2013) Yuji Toiyama et al.   JNCI-Journal of the National Cancer Institute

Association between microRNA polymorphisms and humoral immunity to hepatitis B vaccine

(2013) Yongzhen Xion et al.   Human Vaccines & Immunotherapeutics

Pervasive Transcription of the Human Genome Produces Thousands of Previously Unidentified Long Intergenic Noncoding RNAs

(2013) Matthew J. Hangauer et al.   PLoS Genetics

Landscape of transcription in human cells

(2012) Sarah Djebali et al.   NATURE

High Expression of Wee1 Is Associated with Poor Disease-Free Survival in Malignant Melanoma: Potential for Targeted Therapy

(2012) Gry Irene Magnussen et al.   PLoS One

Forced Mitotic Entry of S-Phase Cells as a Therapeutic Strategy Induced by Inhibition of WEE1

(2012) Marieke Aarts et al.   Cancer Discovery

MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo

(2011) Feizhou Jiang et al.   BMC CANCER

WEE1 Kinase Targeting Combined with DNA-Damaging Cancer Therapy Catalyzes Mitotic Catastrophe

(2011) P. C. De Witt Hamer et al.   CLINICAL CANCER RESEARCH

Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells

(2010) Lili Jiang et al.   BMC CANCER

In Silico Analysis of Kinase Expression Identifies WEE1 as a Gatekeeper against Mitotic Catastrophe in Glioblastoma

(2010) Shahryar E. Mir et al.   CANCER CELL

MicroRNA miR-125b causes leukemia

(2010) M. Bousquet et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA